Pulmonx (LUNG) Operating Expenses (2019 - 2025)

Pulmonx (LUNG) has reported Operating Expenses for 7 consecutive years, with $30.4 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Operating Expenses rose 4.42% year-over-year to $30.4 million in Q3 2025; TTM through Sep 2025 was $124.4 million, a 6.28% increase from a year earlier, with the FY2024 full-year figure at $119.7 million, up 6.23% from the prior year.
• Operating Expenses was $30.4 million for Q3 2025 at Pulmonx, down from $32.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $32.0 million in Q2 2025 and troughed at $19.1 million in Q1 2021.
• A 5-year average of $26.7 million and a median of $28.2 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 73.16% in 2021 and increased 3.37% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at $22.6 million in 2021, then increased by 14.12% to $25.8 million in 2022, then advanced by 9.72% to $28.3 million in 2023, then rose by 9.49% to $31.0 million in 2024, then dropped by 1.81% to $30.4 million in 2025.
• The last three Operating Expenses figures came in at $30.4 million (Q3 2025), $32.0 million (Q2 2025), and $30.9 million (Q1 2025), per Business Quant data.